glp-1 noom Launches Microdose Program, Including Medication and Microhabits Program Noom Enters Longevity Market with
Description
Plan for 10-15% extra to cover waste from dead space and potential reconstitution errors
Christensen, L., Roager, H
Cost is roughly comparable across formats
10.1038/ijo.2013.162 124 VrangN.GroveK
Multi-month options make ongoing care more predictable
While the discourse was less frequent at the beginning of her weight-loss journey, the rise of GLP-1s has meant that more people are flocking to her page to commiserate and strategize
